“Under Fire, Mylan to Offer Generic EpiPen for 50% Less,” was USA Today‘s headline (8/29/16).
That depends on when you start the clock.
The drug-maker announced that it would be selling an unbranded version of the lifesaving anti-allergy device for $300 for a two-pack. That’s actually a little more than a 50 percent reduction from the current list price; a two-pack of EpiPens generally sells for $608.
But that’s the recently jacked-up price that sparked the outrage that forced Mylan to offer a generic alternative. A year ago, an EpiPen set was going for$461. That would make the $300 price a 35 percent reduction, not 50 percent.